MétaCan
Menu
Back to cohort
Record W4389030466 · doi:10.1093/ofid/ofad500.1208

1371. Results From the COVID-19 Vaccines Discrete Choice Experiment Pre-Test Qualitative Interviews in Canada, Germany, the UK, and US General Population

2023· article· en· W4389030466 on OpenAlexaffabout
Sumitra Sri Bhashyam, Lesley G Shane, Hannah B Lewis, Marie de la Cruz, Jayne Galinsky, Keeva Demchuk, Nancy M. Waite, Jeffrey V. Lazarus, David Salisbury

Bibliographic record

VenueOpen Forum Infectious Diseases · 2023
Typearticle
Languageen
FieldSocial Sciences
TopicVaccine Coverage and Hesitancy
Canadian institutionsUniversity of Waterloo
Fundersnot available
KeywordsMedicineCoronavirus disease 2019 (COVID-19)Test (biology)Influenza vaccineFamily medicinePopulationDemographyVaccinationEnvironmental healthImmunologyInternal medicine

Abstract

fetched live from OpenAlex

Abstract Background COVID-19 vaccine preferences can influence vaccine coverage. Discrete choice experiments (DCE) can be used to elicit people’s trade-offs. DCEs require evidence-based attribute selection and validation of understanding with lay audiences. To inform a future DCE, a pre-test was conducted to examine the survey and refine six attributes selected from a targeted literature review and expert interviews. Methods Interviews were conducted in March 2023 in Canada, Germany, the UK, and US. Self-reported anti-vaccinationists were excluded. Eligible individuals were interviewed during the completion of a survey that included 11 choice tasks and supplementary questions. The “think aloud” method was used to evaluate participants’ understanding of the survey and if they were making trade-offs as hypothesized. Four country-level experts validated the survey modifications based on the results. Results Six phone interviews were completed in each country (N=24). Mean age was 43.7; 50% were women; 50% reported receiving the full COVID-19 vaccine series; 45.8% received the initial series but were unsure about additional doses; 1 was unvaccinated (4.2%). Participants’ top four priorities were vaccine protection against COVID-19, serious side-effects, protection against severe COVID-19, and common side-effects, followed by vaccine type and timing of COVID-19/influenza vaccines (Fig 1). More than half of the participants would consider co-administration of COVID-19 and influenza vaccines, either as two separate injections (58.3%) or as a single, combined injection (62.5%) (Fig 2a). Most individuals (54.2%) preferred an annual COVID-19 vaccine; over every 6 months (4.2%), and 20.8% were indifferent (Fig 2b). When deciding to get vaccinated, most considered the following to be important: how long a vaccine was examined in humans (65.2%), how long a vaccine was used in a vaccination program (62.5%); 50% considered vaccine type (mRNA or protein subunit) important (Fig 3). Conclusion This study validated the importance of key vaccine attributes driving people’s choices and feedback was used to improve the clarity of attribute descriptions. A future DCE will be fielded to increase the understanding of COVID-19 vaccine preference and hesitancy. Disclosures Sumitra Sri Bhashyam, MSc, PhD, Novavax Inc: Grant/Research Support L.G Shane, Pharm.D., RPH., BScPharm., Novavax Inc: Employee of Novavax Inc|Novavax Inc: Stocks/Bonds Hannah B. Lewis, MSc, PhD, Novavax Inc: Grant/Research Support Marie de la Cruz, MS, Novavax Inc: Grant/Research Support Jayne Galinsky, PhD, Novavax Inc: Grant/Research Support Keeva Demchuk, n/a, Novavax Inc: Grant/Research Support Nancy M. Waite, Waite PharmD FCCP, GSK: Advisor/Consultant|Novavax Inc: Honoraria|Pfizer: Advisor/Consultant|Sanofi: Advisor/Consultant|Sanofi: Grant/Research Support Jeffrey V. Lazarus, PhD, MIH, MA, AbbVie: Advisor/Consultant|AbbVie: Conference travel|Gilead Sciences: Advisor/Consultant|Gilead Sciences: Grant/Research Support|Gilead Sciences: Honoraria|Moderna: Honoraria|Novavax Inc: Advisor/Consultant|Novavax Inc: Honoraria|Novo Nordisk: Honoraria|Roche Diagnostics: Grant/Research Support David M. Salisbury, CB FMedSci FRCP FRCPCH FFPH, Clover Pharmaceuticals: Advisor/Consultant|GSK: Advisor/Consultant|Moderna: Advisor/Consultant|Novavax Inc: Honoraria|Sanofi: Advisor/Consultant

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.002
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.056
Threshold uncertainty score0.838

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.002
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0010.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.040
GPT teacher head0.382
Teacher spread0.342 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2023
Admission routes2
Has abstractyes

Explore more

Same venueOpen Forum Infectious DiseasesSame topicVaccine Coverage and HesitancyFrench-language works237,207